Consortium to perform human biomonitoring on a European Scale
human biomonitoring for europe
a harmonized approach is feasible
Document Actions

Presentation from hbm week workshops available for download

HBM week November 30th - December 2nd. COPHES and DEMOCOPHES invited scientists, policy makers and stakeholders from different parts of the world in order to exchange on recent experiences, findings and questions in 4 workshops. In the same week, closed sessions dedicated to the progress of the twin projects as well as a training sessions for the 17 implementing countries were organised. A European press Conference was given on Wednesday, 30th of November.


During the workshop representatives of countries all over Europe have presented their experiences and challenges as well as policy implications regarding their bio-monitoring surveillance program. Experiences with who, partnerships with the industry and experiences of the ngo’s have been addressed.

Hbm surveillance program geres in Germany and impact on environmental policy and vci – bmu initiative: partnership between industry and government
Marike Kolossa-Gehring, Uba – Geres

Hbm surveillance program in Slovenia
Milena Horvat, Jožef Stefan Institute

Hbm surveillance program in france: how to define the substances of  interest
Nadine Frery - Institut De Veille Sanitaire - Departement Sante Environnement

Public interest groups’ work on hbm and some perspectives on the european and
international policy landscape
Lisette Van Vliet - Health & Environment Alliance (Heal), Belgium

Hbm surveillance program for pcbs and heavy metals in the Czech Republic
Milena Czerna - National Institute Of Public Health, Czech Republic

Hbm Surveillance Program In Belgium, Flanders: From Biomarker Results To Policy
Greet Schoeters, Vito, Belgium

National hbm surveillance program in Spain
Argelia Castano - Instituto De Salud Carlos Iii, Majadahonda, Madrid

Involvement of cophes/democophes in the development of the Parma hbm indicators of the WHO-Europe Environment And Health Process
Andrey Egorov - World Health Organization, European Centre For Environment And Health, Bonn 

Workshop on Quality of Analytical Data in HBM

During the workshop experts have presented their experiences in quality- and inter-comparability aspects of analytical data focused on Human Biomonitoring.

Sops (german dfg compendium of analytical methods)
Schindler, Koch And Angerer. ipa. Bochum, Germany

Analysis of phthalates metabolites in urine.
Antonia Calafat. cdc, Atlanta Usa

Analysis of cd and creatinine in urine
Mirja Kiilunen. Finnish Institute Of Occupational Health Chemical Safety. Finland

Qmeqas experiences with hair and urine.
Alain Leblanc. Centre De Toxicology. Inspq Quebec. (t.b. c.)

Statistical implications of inter-lab variability for measurements in democophes.
Greet Schoeters, Elly Den Hond.  Vito . Belgium.

“European health examination survey – challenges in the standardization of the collection and analysis of the blood samples”.
Hanna Tolonen . National Institute For Health And Welfare. Helsinki. Finland.

Workshop on Bisphenol A, triclosan and parabens in HBM

During the workshop experts have presented their experiences and challenges as well as policy implications regarding the biomarkers for these compounds.

Main challenges related to the biomarkers for bisphenol a and triclosan exposure
Antonia Calafat, Cdc –Atlanta Usa

Results and assessment of bisphenol a measurements on children in geres iv
Marike Kolossa-Gehring, Uba – Geres ,  Germany

Exposure sources and human levels of bisphenol a and triclosan in Belgium
Tinne Geens, University Of Antwerp,  Belgium

Results of bpa and parabens measurements in hbm studies in Denmark
Hanne Frederiksen - University Hospital, Dept. Growth And Reproduction

Health effects of early, low-level exposure to triclosan in children: triclosan exposure and allergy in 10-year old norwegian children
Randi Bertelsen, National Institute For Environmental Health Sciences , North Carolina, Usa

Bisphenol a: from science to policy
Leo Goeyens, Vub And High Councel Of Health – Working Group Bpa , Belgium

Ngo views on policy responses to bpa, parabens and triclosans. using hbm data to reduce the public’s exposure
Lisette Van Vliet - Health & Environment Alliance (Heal)

Urinary concentrations of bisphenol a in samples of the german environmental specimen bank from 1995 to 2009: a retrospective exposure assessment
Holger Koch, Ipa – Germany

Workshop HBM and indoor/outdoor air quality

Different themes in environment and health (outdoor air quality, indoor air quality and human biomonitoring) have reached at this stage different levels of maturity. 

During the workshop experts have discussed how the different networks (outdoor, indoor an human biomonitoring) have defined exposure/reference values, how these values have been used to communicate with health care professionals, scientists, policy makers or a wider public, how did it worked out  and how each network could benefit from each other.

Case study: role of the EU reference value in the association between PM10 air pollution and infant mortality in Belgium
Hans Scheers, Katholieke Universiteit van Leuven

Case study: Indoor air quality, human biomonitoring and health in Luxembourg
Ralph Baden, Ministère de la Santé du Luxembourg et INTERCIP

Case study: Aphecom: WHO limits and health impact

 Catherine Bouland, University of Brussels, Institute of Public Health

Case study: The need for standardised guideline values to interpret results from inddor air pollution – Priscilla Declercq, Sandrine Bladt, IBGE

Principles for standard setting in EU and US

Bert Brunekreef, IRAS, Universiteit Utrecht

Approaches to define IAQ reference values in Germany
Johannes Schmidt, Institut für Baubiologie + Oekologie IBN

Human biomonitoring as a tool to develop reference values and explore exposure pathways
Marike Kolossa-Gehring, UBA – GerES


Document Actions
  Dr. Reinhard Joas BiPRO GmbH, Munich, Germany
  Dr. Ludwine Casteleyn, Katholieke Universiteit Leuven, Belgium
  Dr. Anke Joas BiPRO GmbH, Munich, Germany